PatientMan
Thanks for your comments. My concern for Syrah and all its shareholders is the time it will take them to get to positive cash flow. They reported they want to raise more funding to cover both the negative cash flow they will experience during start up and for working capital. I personally do not believe it will be enough. With declining market prices, low volume sales the 1st and 2nd year or most likely longer this will result is increase in projected costs and lower basket selling price thus potentially negative profit margins.(They do not define the statement them made to the market that they are 90% sold out. I define sold out as take or pay for 90% of their 1st years capacity and at min price of X.)
Let wait to see what the report in March and then how the start up progresses staring in 3QT its very close now so time will tell if what I am saying is correct.
- Forums
- ASX - By Stock
- SYR
- Syrah with BHP Billiton Management
Syrah with BHP Billiton Management, page-40
Featured News
Add SYR (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.5¢ |
Change
-0.010(4.26%) |
Mkt cap ! $232.8M |
Open | High | Low | Value | Volume |
23.5¢ | 23.5¢ | 22.5¢ | $1.802M | 7.921M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
24 | 1034048 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.0¢ | 443295 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
24 | 1034048 | 0.220 |
11 | 2519858 | 0.215 |
18 | 477024 | 0.210 |
3 | 320000 | 0.205 |
34 | 800565 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.230 | 443295 | 9 |
0.235 | 226020 | 5 |
0.240 | 169251 | 5 |
0.245 | 77688 | 5 |
0.250 | 98737 | 5 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
SYR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online